Sumatriptan Tablet
Product Images NDC 80425-0318

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 80425-0318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

Chemical structure of the active ingredient sumatriptan, showing its molecular components and arrangement including nitrogen, sulfur, and carboxylic acid groups.*

FDA Label Image

Fig 1 (Figure 1)

A line graph showing the estimated probability of response over time in minutes from initial dose for Sumatriptan doses of 25 mg, 50 mg, 100 mg, and placebo. The probability increases over 240 minutes, with higher doses showing greater response rates compared to placebo.*

FDA Label Image

Fig 2 (Figure 2)

A line graph illustrating the estimated probability of headache remission or rescue over 24 hours after an initial dose. The graph compares placebo and three dose levels—25 mg, 50 mg, and 100 mg—showing increasing probabilities over time for each treatment group.*

FDA Label Image

Label 1 (Sumatriptan Succinate 50mg 80425 0318 01)

Sumatriptan Succinate 50 mg tablet packaging label from Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions (20-25°C), a comparison to Imitrex, barcode, lot number, expiration date (9/30/2026), and manufacturer information (Aurobindo Pharm). Label shows it contains 9 tablets.*

FDA Label Image

Label 2 (Sumatriptan Succinate 50mg 80425 0318 02)

Sumatriptan Succinate 50 mg tablet packaging label from Advanced Rx Pharmacy of Tennessee, LLC, Nashville, TN. The label includes a green and white design with text instructions for storage at 20°-25°C (68°-77°F) and comparison to Imitrex. The package contains 36 tablets and notes an expiration date of 9/30/2026.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.